Oxidative metabolites of estrogen and estrogen receptor-mediated genomic and nongenomic signal transduction contribute to the carcinogenicity of estrogen, and thus could initiate, promote, or progress breast cancer [6]. This evidence concerns the gene ESR1 and breast cancer.